Company Overview

Cannabis Global, Inc. (OTC: CBGL) is a U.S.-based cannabis and hemp-related company focused on product development, branding, distribution, and research within the legal cannabis industry. The company has operated primarily in the areas of cannabis-infused consumer products, hemp-derived wellness products, cannabis cultivation-related technologies, and intellectual property development. Public disclosures and OTC market filings indicate that the company has pursued opportunities across both medical and adult-use cannabis segments, with an emphasis on product commercialization and licensing strategies.

The company evolved from earlier business activities tied to cannabis consulting and branding before repositioning toward broader cannabis product development and technology initiatives. Cannabis Global has historically promoted proprietary formulations, cannabinoid delivery systems, and white-label or branded cannabis products targeting dispensaries, distributors, and wellness-oriented consumers. Its strategic positioning has generally centered on participation in emerging cannabis categories while maintaining a relatively asset-light operating structure compared with vertically integrated multi-state operators.

Business Operations

Cannabis Global’s operations have historically included activities associated with cannabis product manufacturing, distribution relationships, intellectual property development, and cannabis-related research initiatives. The company has publicly referenced operations involving cannabinoid formulations, hemp-derived consumer products, and cannabis cultivation technologies. Revenue generation has primarily been tied to product sales, licensing arrangements, consulting-related activities, and commercial partnerships within the cannabis sector, although reported revenues and operational scale have fluctuated over time based on OTC disclosures and company filings.

The company’s business footprint has been concentrated primarily in the United States, particularly in states with legalized cannabis or hemp frameworks. Cannabis Global has at various times referenced proprietary brands and affiliated operating initiatives tied to cannabis science, extraction technologies, and consumer wellness products. Public filings and corporate communications also indicate that the company has pursued collaborations with manufacturers, distributors, and cannabis operators to support commercialization efforts rather than relying exclusively on fully owned cultivation or retail infrastructure. Data regarding the long-term operational scale of some initiatives is inconclusive based on available public sources.

Strategic Position & Investments

Cannabis Global’s strategic direction has generally focused on identifying niche opportunities within the evolving legal cannabis industry, including cannabinoid innovation, hemp-derived wellness categories, and cannabis-related intellectual property. The company has publicly discussed growth initiatives involving research and development, proprietary product formulations, and participation in emerging cannabinoid markets. Its strategy has also included attempts to capitalize on changing cannabis regulations and consumer demand for alternative wellness products.

The company has announced various investments and acquisitions over time involving cannabis technology, product brands, and research-oriented ventures. Public disclosures have referenced interests in cannabis infusion technologies, cultivation-related systems, and cannabinoid commercialization opportunities. However, publicly available information regarding the financial performance, operational status, or long-term integration success of several announced initiatives remains limited. As a result, some historical acquisition and investment outcomes are difficult to independently verify through current public filings alone.

Geographic Footprint

Cannabis Global’s primary operational presence has been in the United States, with headquarters historically reported in California, one of the largest regulated cannabis markets in North America. The company’s activities have largely focused on U.S. cannabis and hemp markets due to federal regulatory constraints affecting broader international expansion opportunities for many smaller cannabis issuers.

While Cannabis Global has referenced broader industry opportunities and international cannabis market trends in public communications, verified operational activity appears concentrated within domestic U.S. markets. The company’s influence outside the United States has primarily been indirect through product concepts, intellectual property positioning, and participation in globally relevant cannabinoid categories rather than through major international operating subsidiaries or large-scale foreign infrastructure investments.

Leadership & Governance

Cannabis Global has operated as a publicly traded OTC company with leadership focused on cannabis commercialization, emerging cannabinoid markets, and investor-facing growth initiatives. Governance and executive structure information has changed periodically over time according to OTC disclosures and corporate filings. The company’s strategic messaging has generally emphasized innovation within cannabis consumer products and the development of scalable intellectual property opportunities tied to evolving cannabis regulations and market demand.

Key executives and leadership figures identified in public disclosures have included:

• Arman Tabatabaei – Chief Executive Officer
• Jerry Schroeder – Former Chief Executive Officer
• Ruben Rivera – Former executive leadership role associated with operations and business development

Publicly available governance information for Cannabis Global is more limited than that of larger SEC-reporting cannabis companies because the company trades on OTC markets and has historically relied on periodic disclosures rather than extensive institutional reporting frameworks. Some executive history and governance details vary across filings and public records; where inconsistencies exist, data is inconclusive based on available public sources.